Investor Ptv Sciences Ii L P
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Ptv Sciences Ii L P . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2021-03-09 13D/A APEN / Apollo Endosurgery Inc 3,302,674 1,355,858
2020-06-18 13D/A APEN / Apollo Endosurgery Inc 3,302,674 3,302,674
2020-06-17 13D/A APEN / Apollo Endosurgery Inc 4,202,140 3,302,674
2017-12-01 13D/A APEN / Apollo Endosurgery Inc 5,464,826 4,202,140
2017-09-25 13D/A APEN / Apollo Endosurgery Inc 4,152,463 5,464,826
2017-01-09 13D APEN / Apollo Endosurgery Inc 4,152,463
2016-01-14 13G/A XENT / Intersect ENT Inc 4,764
2015-02-04 13G XENT / Intersect ENT Inc 2,576,966
2015-01-16 13G/A LDRH / iShares Trust - iShares iBonds 1-5 Year High Yield and Income Ladder ETF 29,473
2014-02-11 13G LDRH / iShares Trust - iShares iBonds 1-5 Year High Yield and Income Ladder ETF 2,039,942